JP2001515900A - 抗ウイルス薬 - Google Patents

抗ウイルス薬

Info

Publication number
JP2001515900A
JP2001515900A JP2000510734A JP2000510734A JP2001515900A JP 2001515900 A JP2001515900 A JP 2001515900A JP 2000510734 A JP2000510734 A JP 2000510734A JP 2000510734 A JP2000510734 A JP 2000510734A JP 2001515900 A JP2001515900 A JP 2001515900A
Authority
JP
Japan
Prior art keywords
hydroxy
amino
hydrogen
hydrazino
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000510734A
Other languages
English (en)
Japanese (ja)
Inventor
マルカッシオ、セバスチャン、マリオ
ジャービス、カレン、エリザベス
Original Assignee
コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション filed Critical コモンウエルス サイエンティフィック アンド インダストリアル リサーチ オーガナイゼーション
Publication of JP2001515900A publication Critical patent/JP2001515900A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/36—Sulfur atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000510734A 1997-09-11 1998-09-11 抗ウイルス薬 Withdrawn JP2001515900A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU9129 1997-09-11
AUPO9129A AUPO912997A0 (en) 1997-09-11 1997-09-11 Antiviral agents
PCT/AU1998/000748 WO1999012927A1 (en) 1997-09-11 1998-09-11 Purine acyclonucleosides as antiviral agents

Publications (1)

Publication Number Publication Date
JP2001515900A true JP2001515900A (ja) 2001-09-25

Family

ID=3803414

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000510734A Withdrawn JP2001515900A (ja) 1997-09-11 1998-09-11 抗ウイルス薬

Country Status (9)

Country Link
EP (1) EP1019404A4 (id)
JP (1) JP2001515900A (id)
KR (1) KR20010023890A (id)
CN (1) CN1269801A (id)
AU (1) AUPO912997A0 (id)
CA (1) CA2302630A1 (id)
ID (1) ID26937A (id)
NZ (1) NZ502994A (id)
WO (1) WO1999012927A1 (id)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022050632A (ja) * 2016-08-29 2022-03-30 エフ．ホフマン－ラ ロシュ アーゲー ウイルス感染の治療又は予防用の７位置換スルホンイミドイルプリノン化合物

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI20022A (sl) * 1998-07-29 2000-02-29 Kemijski inštitut Alkilno substituirani purinovi derivati in njihova priprava
KR100377138B1 (ko) * 1998-11-10 2003-06-12 주식회사 엘지생명과학 퓨린구조를갖는싸이클린의존키나아제저해제,그제조방법및그를함유하는항암제조성물
GB9903762D0 (en) 1999-02-18 1999-04-14 Novartis Ag Organic compounds
CA2405151A1 (en) * 2000-04-07 2001-10-18 University Of Maryland, Baltimore Bile acid containing prodrugs with enhanced bioavailability
US7241890B2 (en) 2001-10-30 2007-07-10 Conforma Therapeutics Corporation Purine analogs having HSP90-inhibiting activity
JP2005535631A (ja) * 2002-06-27 2005-11-24 エフ．ホフマン−ラ　ロシュ　アーゲー プリン誘導体の合成
CN1720246A (zh) * 2003-04-21 2006-01-11 捷克共和国乌斯塔夫化学与生物化学研究院 (嘌呤－6－基)氨基酸及其制备方法
WO2005028434A2 (en) 2003-09-18 2005-03-31 Conforma Therapeutics Corporation Novel heterocyclic compounds as hsp90-inhibitors
CA2602257A1 (en) 2005-03-30 2006-10-05 Conforma Therapeutics Corporation Alkynyl pyrrolopyrimidines and related analogs as hsp90-inhibitors
CN102002043B (zh) * 2010-11-16 2012-10-24 江苏科技大学 4-氨基吡啶催化下的6-甲氧基嘌呤衍生物的合成方法
CN102633767B (zh) * 2012-04-09 2013-10-30 武汉工程大学 一种非离子型碘造影剂中间体2－异丙基－5－羧基－1，3－二氧六环的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216141A (en) * 1988-06-06 1993-06-01 Benner Steven A Oligonucleotide analogs containing sulfur linkages
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022050632A (ja) * 2016-08-29 2022-03-30 エフ．ホフマン－ラ ロシュ アーゲー ウイルス感染の治療又は予防用の７位置換スルホンイミドイルプリノン化合物
JP7214900B2 (ja) 2016-08-29 2023-01-30 エフ．ホフマン－ラ ロシュ アーゲー ウイルス感染の治療又は予防用の７位置換スルホンイミドイルプリノン化合物

Also Published As

Publication number Publication date
NZ502994A (en) 2001-12-21
CA2302630A1 (en) 1999-03-18
WO1999012927A1 (en) 1999-03-18
KR20010023890A (ko) 2001-03-26
AUPO912997A0 (en) 1997-10-02
ID26937A (id) 2001-02-22
EP1019404A1 (en) 2000-07-19
EP1019404A4 (en) 2001-07-04
CN1269801A (zh) 2000-10-11

Similar Documents

Publication Publication Date Title
EP0269574B1 (en) Novel adenosine derivatives and pharmaceutical compositions containing them as an active ingredient
RU2067097C1 (ru) Способ получения дидезоксидидегидрокарбоциклических нуклеозидов
JP3090305B2 (ja) ２−（２−アミノ−１，６−ジヒドロ−６−オキソ−プリン−９−イル）メトキシ−１，３−プロパンジオール誘導体
HU198934B (en) Process for producing 2-aminopurine derivatives and pharmaceutical compositions comprising these compounds as active ingredient
JP2001515900A (ja) 抗ウイルス薬
EP0173624B1 (en) 4-(guanin-9-yl) butanals and antiviral compositions containing them
WO1992009611A1 (en) Pharmaceuticals
CA2098876A1 (en) 2'-deoxy-2',2-'difluoro(2,6,8-substituted)purine nucleosides having anti-viral and anti-cancer activity and intermediates
JPH0240369A (ja) 新規なネプラノシン誘導体類
EP0366385B1 (en) Guanine derivatives having antiviral activity and their pharmaceutically acceptable salts
JPH0755949B2 (ja) 新規ピリド〔２，３−ｄ〕ピリミジン誘導体、その製造方法並びに該化合物を含有する医薬組成物
AU3760793A (en) Antiviral phosphonic acid derivatives of purine analogues
US4060616A (en) Purine derivatives with repeating unit
JPS6363547B2 (id)
US4755516A (en) Antiviral compounds
HU199865B (en) Process for production of healing nucleosides and medical compositions containing them
JP3072600B2 (ja) 新規化合物、その製法及びそれを含む医薬組成物
AU740264C (en) Antiviral agents
JP3068175B2 (ja) イソチアゾロ〔５，４―ｂ〕ピリジン誘導体
JPS635392B2 (id)
JPH06172365A (ja) １０−チアイソアロキサジン誘導体およびその用途
JP2509140B2 (ja) アデノシン誘導体を有効成分として含有する医薬組成物
JPH04279586A (ja) キサンチン誘導体
JPWO2018110591A1 (ja) 抗ウイルス活性を有する２’−デオキシ−７−デアザプリンヌクレオシド誘導体
WO2018110643A1 (ja) 抗ウイルス活性を示すヌクレオシド誘導体

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060110